Abstract:Introduction The ongoing donor kidney shortage has necessitated the increasing use of higher Kidney Donor Profile Index (KDPI) kidneys. Our aim was to investigate machine perfusion (MP) as a strategy to optimise outcomes from these grafts, in particular through the pharmacologic targeting of ischaemia-reperfusion injury (IRI). Materials/Methods (i) A systematic review/meta-analysis was conducted to compare renal transplantation outcomes after hypothermic (HMP) and normothermic (NMP) MP in comparison to static cold storage (CS) using both clinical and experimental data, and thence identify areas for further investigation using animal experimental models. (ii) Directed drug delivery to the kidney, delivered using MP and targeting IRI, was identified as an important area for further research. Three different IRI targets (CD47 antibody, soluble complement receptor 1 [sCR1], and recombinant thrombomodulin [rTM]), delivered intra-renally, were therefore compared in a rodent model of kidney IRI. (iii) NMP was identified as a promising preservation modality for further clinical implementation; therefore a NMP system was developed/optimised using a porcine donation after cirulatory death (DCD) model. The impact of CD47 and sCR1 on NMP parameters was subsequently investigated. Results (i) Hypothermic MP (HMP) reduces kidney delayed graft function in comparison to CS (RR 0.77, 95% CI 0.69 to 0.87), but there is no cumulative study evidence for an improvement in longer-term outcomes. NMP evidence is largely limited to the experimental setting and indicates that NMP is superior to HMP with regards to subsequent renal function (mean difference of peak creatinine -1.66; 95% CI -3.19 to -0.14). Drug delivery targeting IRI is under-explored in MP studies. (ii) A rodent renal IRI model was established, and preliminary evidence (day 1 and 7 renal function and histopathology) indicates intra-renal delivery of CD47 and/or soluble complement receptor 1 may ameliorate IRI. (iii) A clinically translatable NMP system was developed and tested using a porcine kidney donation after circulatory death model. Pressure-controlled perfusion, using a leukocyte-depleted, colloid-containing perfusate produced ideal baseline conditions. Addition of CD47 to the perfusion circuit impacts on perfusion and biochemical parameters, including intra-renal resistance, urine output, and creatinine clearance. Discussion Renal HMP does not seem to modulate longer-term graft outcomes. IRI of the kidney can be ameliorated by the intra-renal delivery of pharmocotherapies such as CD47 blocking antibody. NMP presents the ideal opportunity to deliver such IRI-targeting drugs to the kidney and simultaneously assess kidney function and may enhance the impact of this preservation modality. Conclusion Modification of perfusion conditions using NMP in combination with drug(s) targeting IRI may further improve transplantation outcomes, and avoids systemic treatment of the donor or recipient.

Pharmacologic targeting of renal ischemia-reperfusion injury using a normothermic machine perfusion platform

Intra-Renal Delivery of Drugs Targeting Ischemia-Reperfusion Injury of the Kidney using Normothermic Machine Perfusion

Utilizing pathophysiological concepts of ischemia-reperfusion injury to design renoprotective strategies and therapeutic interventions for normothermic ex vivo kidney perfusion

Nanoparticle Targeting to the Endothelium During Normothermic Machine Perfusion of Human Kidneys

Antioxidant Polysulfide Nanoparticles Ameliorate Ischemia-Reperfusion Injury and Improve Porcine Kidney Function Post-Transplantation

End of preservation normothermic machine perfusion of porcine kidneys after ischaemic injury reprograms metabolism and induces fibrosis after transplant despite unchanged function: insights from the renal proteome.

CD47 blockade reduces ischemia-reperfusion injury and improves outcomes in a rat kidney transplant model

Normothermic Machine Perfusion (NMP) of the Liver as a Platform for Therapeutic Interventions during Ex-Vivo Liver Preservation: A Review

Perfusion Techniques in Kidney Allograft Preservation to Reduce Ischemic Reperfusion Injury: A Systematic Review and Meta-Analysis

Normothermic Machine Perfusion (NMP) Inhibits Proinflammatory Responses in the Liver and Promotes Regeneration

Targeted delivery of galunisertib attenuates fibrogenesis in an integrated ex vivo renal transplant and fibrosis model

Metformin Preconditioning and Postconditioning to Reduce Ischemia Reperfusion Injury in an Isolated Ex Vivo Rat and Porcine Kidney Normothermic Machine Perfusion Model

Prolonged ex-vivo normothermic kidney perfusion: The impact of perfusate composition

Os003 ipc reduces iri in the rat kidney byrepressing its unique microrna expression profile

Cold Preflush of Porcine Kidney Grafts Prior to Normothermic Machine Perfusion Aggravates Ischemia Reperfusion Injury

Complement Is Activated During Normothermic Machine Perfusion of Porcine and Human Discarded Kidneys

CC-4066 therapy delivered to kidneys during cold storage and assessed with normothermic reperfusion is feasible and safe

Improving Liver Graft Function Using CD47 Blockade in the Setting of Normothermic Machine Perfusion

Anti‐CD47 monoclonal antibody therapy reduces ischemia‐reperfusion injury of renal allografts in a porcine model of donation after cardiac death

Impact of device variability and protocol differences on kidney function during normothermic machine perfusion: A comparative study using porcine and human kidneys

Evaluating the Effects of Subnormothermic Perfusion with AP39 in a Novel Blood-Free Model of Ex Vivo Kidney Preservation and Reperfusion